In the Whitehall II study, for example, high levels of CRP and IL-6 at baseline have been associated with an increased risk of future cognitive symptoms of depression whereas baseline symptoms of depression did not predict the level of CRP or IL-6 at follow-up (Gimeno et al., 2009). This evidence concerns the gene CRP and major depressive disorder.